Company overview
Richter BioLogics is a Germany-based CDMO specializing in microbial production of biologics from bacteria and yeasts, including recombinant proteins, peptides, VHH/nanobodies, plasmid DNA, and bacterial vaccines. It offers cGMP-compliant services from cell line and process development to commercial manufacturing across fermenter scales of 10L to 1,500L in three facilities. With over 35 years of experience, the company supports E. coli, P. pastoris, cell-free systems, and additional strains.
European Biologics CDMO based in Germany is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services, CDMO & Manufacturing partner serving United States & Americas. Core focus areas include richter biologics, microbial cdmo, biologics manufacturing, nanobodies, plasmid dna, e. coli production.
Industry categories: CRO & Clinical Services, CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with European Biologics CDMO based in Germany include Cdmo, Cro — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.richterbiologics.eu
- Categories
- CRO & Clinical Services, CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- richter biologics, microbial cdmo, biologics manufacturing, nanobodies, plasmid dna, e. coli production, p. pastoris, cgmp biologics
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What production systems and scales does Richter BioLogics support?
- Specializes in E. coli, P. pastoris, and cell-free (CFPS) systems, with support for additional microbial strains. Offers fermentation capacities from 10L to 1,500L across three facilities, including 2 x 1,500L and 2 x 300L.
- What types of biologics does Richter BioLogics manufacture?
- Produces recombinant proteins and peptides, antibody-like scaffolds (VHH/nanobodies, Fab fragments), plasmid DNA (pDNA) via proprietary RB-pART process, and bacterial vaccines.
- What regulatory standards and locations apply to Richter BioLogics?
- Operates cGMP-compliant facilities in Germany (Hamburg and Bovenau), with additional sites in Hungary. Focuses on microbial expression for biopharmaceuticals meeting stringent industry standards.
Related editorial coverage
- IPEC Excipient World Biologics Summit 2026: Recap
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
